Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548
出版年份 2020 全文链接
标题
Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-09-14
DOI
10.1186/s13046-020-01697-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Roles of circRNAs in the tumour microenvironment
- (2020) Qiuge Zhang et al. Molecular Cancer
- Circular RNAs: Potential Regulators of Treatment Resistance in Human Cancers
- (2020) Shivapriya Jeyaraman et al. Frontiers in Genetics
- New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
- (2019) Daniela Criscuolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
- (2019) Francesco Morra et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2019) Sumanta K. Pal et al. JOURNAL OF CLINICAL ONCOLOGY
- Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma
- (2019) Alaa Habieb et al. MOLECULAR BIOLOGY REPORTS
- Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
- (2019) Min Su et al. Molecular Cancer
- Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence
- (2019) Junming Bi et al. Molecular Cancer
- Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis
- (2019) Feng Liu et al. ONCOGENE
- Circular RNA circPICALM sponges miR-1265 to inhibit bladder cancer metastasis and influence FAK phosphorylation
- (2019) Dong Yan et al. EBioMedicine
- circ5912 suppresses cancer progression via inducing MET in bladder cancer
- (2019) Yinjie Su et al. Aging-US
- Involvement of Prokineticin 2–expressing Neutrophil Infiltration in 5-Fluorouracil–induced Aggravation of Breast Cancer Metastasis to Lung
- (2018) Soichiro Sasaki et al. MOLECULAR CANCER THERAPEUTICS
- Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
- (2018) Yu Yoshida et al. Oncotarget
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- CircRNA: functions and properties of a novel potential biomarker for cancer
- (2017) Shujuan Meng et al. Molecular Cancer
- CircRNA: a novel type of biomarker for cancer
- (2017) He-da Zhang et al. Breast Cancer
- MiR-548an, Transcriptionally Downregulated by HIF1 /HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression
- (2016) S. Zhu et al. MOLECULAR CANCER THERAPEUTICS
- A PK2/Bv8/PROK2 Antagonist Suppresses Tumorigenic Processes by Inhibiting Angiogenesis in Glioma and Blocking Myeloid Cell Infiltration in Pancreatic Cancer
- (2013) Valerie F. Curtis et al. PLoS One
- Prokineticins in angiogenesis and cancer
- (2010) Justin Monnier et al. CANCER LETTERS
- Kallmann syndrome
- (2008) Catherine Dodé et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Disruption of the Circadian Output Molecule Prokineticin 2 Results in Anxiolytic and Antidepressant-like Effects in Mice
- (2008) Jia-Da Li et al. NEUROPSYCHOPHARMACOLOGY
- Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma
- (2008) Justin Monnier et al. WORLD JOURNAL OF GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started